Skip to main content

Dibenzazepine

ADVERTISEMENT
Identification
Molecular formula
C14H13N
CAS number
256-75-7
IUPAC name
6,11-dihydro-5H-benzo[b][1]benzazepine
State
State

At room temperature, dibenzazepine is in a solid state. It is typically handled as a solid powder in chemical laboratories.

Melting point (Celsius)
73.00
Melting point (Kelvin)
346.15
Boiling point (Celsius)
340.00
Boiling point (Kelvin)
613.15
General information
Molecular weight
193.26g/mol
Molar mass
193.2600g/mol
Density
1.1897g/cm3
Appearence

Dibenzazepine appears as white to off-white crystalline powder. It may also appear as needles or flakes depending on the method of solidification.

Comment on solubility

Solubility of 6,11-dihydro-5H-benzo[b][1]benzazepine

The solubility of 6,11-dihydro-5H-benzo[b][1]benzazepine in various solvents confers significant implications for its applications in pharmaceutical and chemical research. Understanding its solubility profile can help predict its behavior in different environments. Below are key aspects of its solubility:

  • Solvent Dependence: The solubility of this compound often varies depending on the solvent used. It is crucial to conduct solubility tests in both polar and non-polar solvents to obtain a complete understanding.
  • Polar Solvents: Generally, compounds with more hydrophobic characteristics exhibit lower solubility in polar solvents like water. Therefore, it can be expected that 6,11-dihydro-5H-benzo[b][1]benzazepine has limited solubility in water.
  • Non-Polar Solvents: In contrast, higher solubility may be observed in non-polar solvents such as hexane or toluene, aligning with its aromatic structure.
  • Temperature Effects: As with many organic compounds, solubility may improve with increasing temperature; hence, elevated temperatures can enhance its dissolution in suitable solvents.

In conclusion, while 6,11-dihydro-5H-benzo[b][1]benzazepine may present limited solubility in aqueous solutions, its solubility in non-polar solvents opens up potential pathways for formulation and application in various fields. Understanding these solubility dynamics can be invaluable for scientists working with this compound.

Interesting facts

Exploring 6,11-Dihydro-5H-Benzo[b][1]Benzazepine

6,11-Dihydro-5H-benzo[b][1]benzazepine is a fascinating chemical compound that belongs to the class of heterocyclic organic compounds. It features a unique bicyclic structure, which gives it intriguing properties and potential applications. Here are some captivating facts about this compound:

  • Structural Complexity: The compound consists of fused benzene rings that contribute to its extensive π-electron system, making it a subject of interest in the fields of organic chemistry and materials science.
  • Potential Pharmacological Applications: Compounds such as 6,11-Dihydro-5H-benzo[b][1]benzazepine have been researched for their potential therapeutic effects. They may exhibit activities that could be beneficial in treating various medical conditions.
  • Role in Chemical Synthesis: Due to its unique structure, this compound serves as an essential building block in the synthesis of more complex molecules, demonstrating its versatility in chemical research and development.
  • Researchers' Interest: The compound's unique properties have drawn the attention of researchers aiming to understand its reactivity and interactions with other molecules, signaling its potential in advancing chemical knowledge. As one chemist noted, “Every compound tells a story, and 6,11-Dihydro-5H-benzo[b][1]benzazepine is no different.”

In conclusion, 6,11-Dihydro-5H-benzo[b][1]benzazepine is more than just a chemical formula; it embodies a wealth of potential in various scientific fields, showcasing the intricate relationships between structure, reactivity, and application. As research progresses, this compound may unveil more of its secrets, promising exciting advancements in chemistry.

Synonyms
Iminodibenzyl
494-19-9
10,11-Dihydro-5H-dibenzo[b,f]azepine
Iminobibenzyl
10,11-Dihydro-5H-dibenz[b,f]azepine
2,2'-Iminodibenzyl
2,2'-Iminobibenzyl
Iminodibenyl
5H-Dibenz[b,f]azepine, 10,11-dihydro-
10,11-Dihydrodibenz(b,f)azepine
RP 23669
NSC 72110
10,11-Dihydro-5-dibenz(b,f)azepine
5H-Dibenz(b,f)azepine, 10,11-dihydro-
EINECS 207-787-1
10,11-Dihydro-5H-dibenz(b,f)azepine
BRN 0152732
262BX7OE3U
DTXSID8049414
AI3-39165
10,11-Dihydrodibenz[b,f]azepine
NSC-72110
DTXCID7029374
EC 207-787-1
5-20-08-00092 (Beilstein Handbook Reference)
CARBAMAZEPINE IMPURITY E [IP]
CARBAMAZEPINE IMPURITY E [EP IMPURITY]
10,11-DIHYDRO-5H-DIBENZ(B.F)AZEPINE
10,11-DIHYDRO-5H-DIBENZO(B,F)AZEPINE
TRIMIPRAMINE MALEATE IMPURITY F [EP IMPURITY]
CLOMIPRAMINE HYDROCHLORIDE IMPURITY E [EP IMPURITY]
CARBAMAZEPINE IMPURITY E (IP)
CARBAMAZEPINE IMPURITY E (EP IMPURITY)
TRIMIPRAMINE MALEATE IMPURITY F (EP IMPURITY)
CLOMIPRAMINE HYDROCHLORIDE IMPURITY E (EP IMPURITY)
TRIMIPRAMINE MALEATE IMPURITY, IMINODIBENZYL-(USP IMPURITY)
TRIMIPRAMINE MALEATE IMPURITY, IMINODIBENZYL-[USP IMPURITY]
5H-Dibenzb,fazepine, 10,11-dihydro-
207-787-1
inchi=1/c14h13n/c1-3-7-13-11(5-1)9-10-12-6-2-4-8-14(12)15-13/h1-8,15h,9-10h
6,11-dihydro-5H-benzo[b][1]benzazepine
MFCD00005070
CHEMBL63054
10,11-Dihydro-5H-dibenzo[b,f]azepine (Iminodibenzyl)
CAS-494-19-9
UNII-262BX7OE3U
Iminodibenzyyl
Clomipramine HCl EP Impurity E
10,f]azepine
Carbamazepine impurity E
Oprea1_136738
SCHEMBL407439
WLN: T C676 BM&T&J
5H-Dibenz[b, 10,11-dihydro-
HY-B2131
NSC72110
STR02159
Tox21_113758
Tox21_202836
BBL011749
BDBM50012879
STK299261
2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaene
AKOS000119140
AC-7238
FI01651
GF-0137
NCGC00253630-01
NCGC00260382-01
10,11-Dihydro-5H-dibenz [b,f]azepine
PD065559
SY005302
10,11-Dihydro-5H-dibenzo[b,f]azepine #
5H-Dibenzo[b,f]azepine, 10,11-dihydro-
CS-0020288
D0269
NS00005580
EN300-19086
10,11-Dihydro-5H-dibenz[b,f]azepine, 97%
IMINODIBENZYL TRIMIPRAMINE [USP IMPURITY]
SR-01000395830
Q1096623
SR-01000395830-1
Iminodibenzyl (10,11-Dihydro-5H-dibenzo[b,f]azepine)
Z104472710
Iminodibenzyl, United States Pharmacopeia (USP) Reference Standard
2-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,11,13-hexaene
Iminodibenzyl, Pharmaceutical Secondary Standard; Certified Reference Material